NCT05301920 The Evaluation of the Transcutaneous Electrical Stimulation Medical Device's Safety and Effectiveness in Treating the Patients With Migraine Status COMPLETED Phase NA
NCT05292599 Effect of a Home-based Versus Supervised Exercise Program in Patients With Migraine Status COMPLETED Phase NA
NCT05285852 Effects Of Dry Needling On Sternocleidomastoid Muscle For Pain And Disability In Migraine Status COMPLETED Phase NA
NCT05284019 Real World Effectiveness of Eptinezumab in Participants With Migraine Status TERMINATED Phase PHASE4
NCT05281770 Monoclonal CGRP Antibodies for Migraine Prevention - a Nationwide Real Life Study Status RECRUITING Phase N/A
NCT05278325 Improved Treatment Course for Patients With Migraine and Tension-type Headache Status COMPLETED Phase NA
NCT05232942 Monoclonal Antibody Duration of REsponse in MIgraine After Treatment Interruption Status RECRUITING Phase N/A
NCT05217927 Efficacy and Safety Study of Rimegepant in Episodic Migraine Prevention With Multiple Dosing Regimens Status COMPLETED Phase PHASE4
NCT05207865 Safety and Tolerability Study of Daily Dosing Rimegepant in Episodic Migraine Prevention Status COMPLETED Phase PHASE4
NCT05202171 The Effects of Cervical Stabilization Exercise Training With Telerehabilitation in Individuals With Migraine Status UNKNOWN Phase NA
NCT05199064 Efficacy of Greater Occipital Nerve Radiofrequency for Refractory Migraine Treatment Status COMPLETED Phase N/A
NCT05198245 Study of Pregnancy Outcomes in Women Exposed to Rimegepant During Pregnancy Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05177406 Healthcare Costs and Resource Utilization in Aimovig Migraine Patients: a Retrospective Study Using United States Claims Data Status COMPLETED Phase N/A
NCT05175521 Inhaled IAV vs Inhaled Eucalyptus for the Treatment of Nausea With Acute Migraine Status COMPLETED Phase NA
NCT05164172 A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine Status RECRUITING Phase PHASE3
NCT05162664 Presence of Signs of Central Sensitization in Episodic and Chronic Migraine Status COMPLETED Phase NA
NCT05161871 Transcranial Direct Current Stimulation Plus Monoclonal Antibodies Acting on the CGRP Pathway for Migraine Status COMPLETED Phase NA